277 related articles for article (PubMed ID: 38390449)
1. Intercellular communication in peritoneal dialysis.
Sheng L; Shan Y; Dai H; Yu M; Sun J; Huang L; Wang F; Sheng M
Front Physiol; 2024; 15():1331976. PubMed ID: 38390449
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
[TBL] [Abstract][Full Text] [Related]
3. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
4. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.
Schilte MN; Celie JW; Wee PM; Beelen RH; van den Born J
Perit Dial Int; 2009; 29(6):605-17. PubMed ID: 19910560
[TBL] [Abstract][Full Text] [Related]
5. Recent Understanding of Peritoneal Pathology in Peritoneal Dialysis Patients in Japan.
Hamada C; Tomino Y
Blood Purif; 2021; 50(6):719-728. PubMed ID: 33567422
[TBL] [Abstract][Full Text] [Related]
6. Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.
Vila Cuenca M; Keuning ED; Talhout W; Paauw NJ; van Ittersum FJ; Ter Wee PM; Beelen RHJ; Vervloet MG; Ferrantelli E
Int Urol Nephrol; 2018 Jun; 50(6):1151-1161. PubMed ID: 29728994
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-packaged ILK from mesothelial cells promotes fibroblast activation in peritoneal fibrosis.
Huang Q; Sun Y; Peng L; Sun J; Sha Z; Lin H; Li Y; Li C; Li H; Shang H; Chen Y; Dou X; Hu Z; Ye Z; Peng H
J Extracell Vesicles; 2023 Jul; 12(7):e12334. PubMed ID: 37357686
[TBL] [Abstract][Full Text] [Related]
8. IL-6
Yang X; Yan H; Jiang N; Yu Z; Yuan J; Ni Z; Fang W
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F338-F353. PubMed ID: 31841386
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis.
Masola V; Bonomini M; Borrelli S; Di Liberato L; Vecchi L; Onisto M; Gambaro G; Palumbo R; Arduini A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563220
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis.
López-Cabrera M
Adv Med; 2014; 2014():473134. PubMed ID: 26556413
[TBL] [Abstract][Full Text] [Related]
12. Complement system activation and peritoneal membrane alterations: Culprit or innocent bystander?
Borceux P; Morelle J; Goffin E
Perit Dial Int; 2020 Mar; 40(2):115-123. PubMed ID: 32063185
[TBL] [Abstract][Full Text] [Related]
13. The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis.
Wang L; Zhuang S
Perit Dial Int; 2015; 35(5):497-505. PubMed ID: 26450477
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronan.
Yung S; Chan TM
J Biomed Biotechnol; 2011; 2011():180594. PubMed ID: 22203782
[TBL] [Abstract][Full Text] [Related]
15. microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis.
Lopez-Anton M; Bowen T; Jenkins RH
Biomed Res Int; 2015; 2015():929806. PubMed ID: 26495316
[TBL] [Abstract][Full Text] [Related]
16. How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient's Health).
Bonomini M; Masola V; Procino G; Zammit V; Divino-Filho JC; Arduini A; Gambaro G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360717
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients.
Zarrinkalam KH; Stanley JM; Gray J; Oliver N; Faull RJ
Kidney Int; 2003 Jul; 64(1):331-8. PubMed ID: 12787426
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis.
Gillerot G; Devuyst O
Clin Nephrol; 2003 Jul; 60(1):1-6. PubMed ID: 12872851
[TBL] [Abstract][Full Text] [Related]
19. Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.
Roumeliotis S; Dounousi E; Salmas M; Eleftheriadis T; Liakopoulos V
Biomolecules; 2020 May; 10(5):. PubMed ID: 32423139
[TBL] [Abstract][Full Text] [Related]
20. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
